Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
INInspire Medical Systems, Inc. logo

Inspire Medical Systems, Inc. (INSP)

New York Stock Exchange · Currency in USD
$71.11 ▼ -1.55 (-2.13%)
At close: Oct 23, 4:00 PM ET. Market closed.
$71.11 ▲ +0.00 (+0.00%)
After hours: Oct 23, 5:22 PM ET

Summary

Previous Close
$72.66
Open
$72.25
Day's Range
$68.46 – $72.78
52 Week Range
$38.91 – $147.03
Volume
557,021
Avg. Volume
870,054
Market Cap
$2.06B
Beta (5Y Monthly)
0.73
PE Ratio (TTM)
15.26
EPS (TTM)
$4.68
Earnings Date
Nov 2, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
Jan 9, 2008
1y Target Est
$63.00

Profile: Inspire Medical Systems, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
1,333
CEO
Timothy Herbert

Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway.

Earnings

Next report: Mon, Nov 2, 2026
EPS estimate $0.09 · Revenue est. $204.31M
DateEst.Actual
Aug 3, 2026-$0.24$0.14Beat
May 4, 2026-$0.28$0.10Beat
Feb 11, 2026$0.69$1.65Beat
Nov 3, 2025-$0.15$0.38Beat
Aug 4, 2025$0.22$0.45Beat
May 5, 2025-$0.23$0.10Beat

Analyst view

Consensus price target
$63.00 ▼ -11.4%
Range $39.00 – $85.00
Rating: Hold
Buy 43% · Hold 57% · Sell 0%

Get free alerts on INSP and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.